Insulin Lispro rDNA origin 100iU/ml, 3 ml Injection PFS
Indian Air Force · Kanpur · Pharmaceuticals · open
Key facts
- Tender value: ₹11.9L
- EMD: ₹36K
- Closing date: 19 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of Insulin Lispro rDNA origin 100iU/ml, 3 ml Injection PFS by the Indian Air Force, Ministry of Defence, Department of Military Affairs. Total quantity 1500 units. Bid opening on 19-08-2026. Estimated bid value approximately 1,192,810 INR. Includes EMD of 35,784 INR and ePBG of 3%. The tender emphasizes MII and MSE preferences, technical specifications, and qualification criteria.
Eligibility & requirements
- Experience required: 3 years
- Past performance: 80%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience proof, Turnover proof, OEM authorization, Certificates
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Insulin Lispro rDNA origin 100iU/ml, 3 ml Injection PFS — Qty: 1500 unit
1 tender document(s) available — sign up to download.